新生儿用药的安全性
Medication Safety in Neonates
Newborn intensive care units (NICUs) are high-risk areas of care, where complex medical interventions are performed, and are recognized as a resource for improved outcome in premature and low-birth-weight infants or those presenting with acute conditions. This critical environment, along with the vulnerable nature of the population it serves, places patients at risk for medication errors, which can result in permanent harm or death. Promoting safe medication practices requires participation of all individuals involved in the medication use process (e.g., physicians, nurses, nurse practitioners, physician assistants, pharmacists, respiratory therapists, pharmacy technicians). The following recommendations, organized in accordance with the Institute for Safe Medication Practices' Key Elements of the Medication Use SystemTM, will focus on significant areas of concern within the NICU. All individuals caring for neonates, supported by administrators and organizational leaders, should recognize themselves as active partners responsible for the safety of this fragile patient population by participating in the design and sustainment of a safe and efficient medication use system.
上一篇: 新生儿缺血缺氧中的心脏生物标志物
学科代码:儿科学 关键词:新生儿用药的安全性
来源: Eclips
来源: Eclips
Eclips介绍:Eclips由权威专家阅读世界顶级医学期刊(包括New England Journal of Medicine, The Lancet, JAMA, BMJ 等)后筛选出最顶尖的文章,并总结、分级和点评,为繁忙的临床医生提供最快、最有效的前沿医学信息,并同时提供临床医生参与点评文献和同行互动交流的学术平台。 请点击申请试用并填写联系信息,我们将每月为前100位申请者发送带有用户名、密码及网页链接的电子邮件,请您注意查收!感谢您的参与及使用! 马上访问Eclips网站http://eclips.consult.com/
顶一下(0)
- 您可能感兴趣的文章
-